Early Oral Development Partnering Opportunities for Clinical Success
Date: May 7, 2024
Time: 12:00 PM – 4.30 PM CEST
Location: Munich, Germany
Strategic partnerships with CDMOs can offer pharmaceutical companies access to cutting-edge technologies, specialized expertise, and flexible manufacturing solutions that can adapt to the evolving demands of the pharmaceutical market. This is particularly relevant for small and mid-sized pharma companies that may not have the in-house capabilities to carry out all aspects of drug development and manufacturing. However, there are still unique challenges associated with the successful development and manufacturing of Investigational Medicinal Products that require strategic planning, innovative development, and clinical supply solutions. This small molecule focused event brings together pharmaceutical experts to discuss such challenges and offer solutions for improving bioavailability, applying different pharmaceutical technologies for dosage form designs, optimizing manufacturing, and accelerating progression to the clinic and on to market success.
AGENDA
TIME
SESSION
SPEAKERS
Giovanna Sicilia
Account Executive, Clinical Development and Supply
Catalent
Steven Winling
Scientific Advisor
Catalent
Claire Quinn
Clinical Supply Manager
Catalent
Connor Callaghan
Senior Project Manager – Integrated Projects Manufacturing
Catalent
Elena Meurer
Principal Consultant
Cencora Pharmalex
Giovanna Sicilia
Account Executive, Clinical Development and Supply
Catalent
Katharina Leibacher
Account Director, Clinical Development and Supply
Catalent